A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

11.6K views

⸱

DOI:

10.3791/54624

⸱

December 22nd, 2016

In This Article

Summary

This manuscript provides a description of the methodology used to establish transduction-transplantation mouse models. A detailed account is given of technical errors to avoid when performing bone marrow transplants. A clear understanding should be gained of the importance of high viral titer, transfection/transduction, and irradiation.

Abstract

Transduction-transplantation is a quick and efficient way to model human hematologic malignancies in mice. This technique results in expression of the gene of interest in hematopoietic cells and can be used to study the gene's role in normal and/or malignant hematopoiesis. This protocol provides a detailed description on how to perform transduction-transplantation using calreticulin (CALR) mutations recently identified in myeloproliferative neoplasm (MPN) as an example. In this protocol whole bone marrow cells from 5-flurouracil (5-FU) treated donor mice are transduced with a retrovirus encoding mutant CALR and transplanted into lethally irradiated syngeneic hosts. Donor cells expressing mutant CALR are marked with green fluorescent protein (GFP). Transplanted mice develop an MPN phenotype including elevated platelets in the peripheral blood, expansion of megakaryocytes in the bone marrow, and bone marrow fibrosis. We provide a step-by-step account of how to generate retrovirus, calculate viral titer, transduce whole bone marrow cells, and transplant into irradiated recipient mice.

Introduction

Transduction-transplantation is a useful method to model hematologic malignancies in mice. This technique has been particularly valuable for studying myeloid malignancies dating back to the first demonstration that ectopic expression of BCR-ABL1 could faithfully recapitulate chronic myelogenous leukemia in mice1. This technique has subsequently facilitated the extensive study of JAK2V617F and MPLW515K/L mutated myeloproliferative neoplasm (MPN).

MPN are a group of hematologic malignancies characterized by the overproduction of mature myeloid cells and bone marrow fibrosis. These diseases generally arise from....

Access restricted. Please log in or start a trial to view this content.

Protocol

This study was approved and carried out in accordance with the recommendations by the Institutional Animal Care and Use Committee at University of California, Irvine. All procedures were performed under isoflurane anesthesia and all efforts were made to minimize suffering.

1. Generation of Ecotropic Retrovirus

  1. Prepare high-quality plasmids with a concentration of at least 1 µg/µl using either a commercial maxi-prep kit or cesium chloride purification.
    NOTE: These include an MSCV backbone vector encoding the gene of interest (in this case CALR7,8) and marker of choice (GFP, Neo, etc.) as well as a....

Access restricted. Please log in or start a trial to view this content.

Results

The transduction-transplantation technique results in hematopoietic reconstitution of the recipient mice with cells expressing the gene of interest. Figure 1 shows an overview of the transduction-transplantation mouse model of calreticulin mutated MPN. Briefly, retrovirus expressing CALRwt or CALRdel52 is used to infect BM cells from a C57B/6 donor mouse. Transduced cells are transplanted into irradiated C57B/6 recipient mouse and donor cell engraftment occurs during the .......

Access restricted. Please log in or start a trial to view this content.

Discussion

This protocol provides a detailed description of how to perform bone marrow transplants in mice to recapitulate an essential thrombocythemia-like disease with progression to myelofibrosis with CALRdel52 mutation as the driver of disease. Successful transplantation of cells expressing CALRdel52 results in increased platelets, expansion of megakaryocytes, and bone marrow fibrosis. As bone marrow transplantation is a multistep process, it is important to acknowledge steps where technical error can be avoided to prevent poor.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This work is supported by the V Foundation Scholar (AGF) and the MPN Research Foundation (AGF).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Cell Lines
DMEMCorningMT-10-013-CV
293T cellsATCCCRL-11268
3T3 cellsATCCCRL-1658
Plasmids
EcoPak, also known as pCL-EcoAddgene12371Retroviral packaging cell lines, such as EcoPack 2-293, may be used in place of the EcoPak plasmid and standard 293T cells. Additional γ-retrovirus envelope and packaging plasmids are available from Addgene and others.
MSCV-IRES-GFP (MIG)Addgene20672Additional γ-retroviral transfer plasmids are available from Addgene and others.
Consumables
27 G x 1/2" needlesBD305620
Fetal bovine serumCorningMT-35-010-CV
Penicillin/streptomycin/L-glutamineCorningMT-30-009-CI
Trypsin-EDTA (0.05%)CorningMT-25-052-CICan be homemade
PBSCorningMT-21-031-CV
10 cm dishesFisher172931
15 ml conical tubesFisher12565268
60 mm dishesFisher150288
PolybreneFisherNC9840454
5-FUFisherA13456-06
100 µm cell strainersFisher22363549
50 ml conical tubesFisher12565270
6-well plateFisher130184
FACS tubesFisher14-959-5
0.45 μm syringe filtersFisher0974061B
Opti-MEMGibco31985-070
ACK bufferLonza10-548ECan be homemade
Recombinant murine IL-3Peprotech213-13
Recombinant murine IL-6Peprotech216-16
Recombinant murine SCFPeprotech250-03
X-tremeGENE 9Roche6365809001Transfection reagent
1.5 ml centrifuge tubesUSA Scientific1615-5500
Equipment
BD Accuri C6
X-ray irradiator

References

  1. Daley, G. Q., Van Etten, R. A., Baltimore, D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science(New York, N.Y.). 247 (4944), 824-830 (1990).
  2. Wernig, G., Mercher, T., Okabe, R., Levine, R. L., Lee, B. H., Gilliland, D. G.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Calreticulin MutationBone Marrow TransplantationRetroviral TransductionGFP ExpressionHematopoietic CellsViral Titer Calculation5-FU TreatmentIrradiated Recipient Mice